Damora Therapeutics, Inc. (DMRA)
Pharmaceutical Preparations · Healthcare · $1.2B
Intrinsic Value (Consensus)
$45.71
Current Price
$20.59
Margin of Safety
+122%
122% Below Intrinsic Value
Value: $46
Price: $21
Valuation Model Estimates
Current Price: $20.59
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$18.89
Earnings Power Value
$38.64
Relative Value (P/E)
$79.60
Dividend Discount Model
Not applicable
—
Consensus Value
$45.71
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
43
Profitability
10/25
Strength
7/25
Valuation
22/25
Growth
4/25
Financial Health Signals
Negative return on equity — company is losing money on shareholder capital
Negative free cash flow — company is burning cash
Key Financials
- EPS (TTM)
- $3.98
- EPS (Forward)
- $4.18
- Book Value
- $3.99
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- -87.3%
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance